Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
Abstract Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-19 pneumonia. Methods A retrospective study based on propensity score matching was designed to explore the effects of corticosteroids. Primary outcomes included the rate of patients who developed seve...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-09-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-020-00332-3 |
id |
doaj-a2c9963fba934a2bbb930ad71ff0676f |
---|---|
record_format |
Article |
spelling |
doaj-a2c9963fba934a2bbb930ad71ff0676f2021-09-05T11:14:35ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822020-09-019482383610.1007/s40121-020-00332-3Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort StudyQiang Li0Weixia Li1Yinpeng Jin2Wei Xu3Chenlu Huang4Li Li5Yuxian Huang6Qingchun Fu7Liang Chen8Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Infectious Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityDepartment of Liver Disease, Shanghai Public Health Clinical Center, Fudan UniversityAbstract Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-19 pneumonia. Methods A retrospective study based on propensity score matching was designed to explore the effects of corticosteroids. Primary outcomes included the rate of patients who developed severe disease and mortality. Secondary outcomes included duration of fever, virus clearance time, length of hospital stay, and the use of antibiotics. Results A total of 475 patients with non-severe COVID-19 pneumonia were enrolled, 55 patients received early, low-dose, and short-term corticosteroids therapy, 420 patients received non-corticosteroids therapy. Compared to the non-corticosteroids group, there was a prolonged duration of fever (median 5 vs 3 days, p < 0.001), virus clearance time (median 18 vs 11 days, p < 0.001), and length of hospital stay (median 23 vs 15 days, p < 0.001) in the corticosteroids group. The percentages of antibiotics therapy (89.1% vs 23.6%, p < 0.001), use of at least two antibiotics (38.2% vs 12.7%, p = 0.002), and antifungal therapy (7.3% vs 0, p = 0.042) were higher in the corticosteroids group than those in the non-corticosteroids group. Compared to the non-corticosteroids group, more patients developed severe disease (12.7% vs 1.8%, p = 0.028) in the corticosteroids group. There was no significant difference between the two groups in mortality (1.8% vs 0, p = 0.315). Conclusion In adult patients with non-severe COVID-19 pneumonia, early, low-dose, and short-term corticosteroids therapy was associated with worse clinical outcomes.https://doi.org/10.1007/s40121-020-00332-32019 novel coronavirus diseaseCorticosteroidsEfficacy evaluationNon-severe COVID-19 infectionsSevere acute respiratory syndrome coronavirus 2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qiang Li Weixia Li Yinpeng Jin Wei Xu Chenlu Huang Li Li Yuxian Huang Qingchun Fu Liang Chen |
spellingShingle |
Qiang Li Weixia Li Yinpeng Jin Wei Xu Chenlu Huang Li Li Yuxian Huang Qingchun Fu Liang Chen Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study Infectious Diseases and Therapy 2019 novel coronavirus disease Corticosteroids Efficacy evaluation Non-severe COVID-19 infections Severe acute respiratory syndrome coronavirus 2 |
author_facet |
Qiang Li Weixia Li Yinpeng Jin Wei Xu Chenlu Huang Li Li Yuxian Huang Qingchun Fu Liang Chen |
author_sort |
Qiang Li |
title |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
title_short |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
title_full |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
title_fullStr |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
title_full_unstemmed |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
title_sort |
efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe covid-19 pneumonia: a retrospective cohort study |
publisher |
Adis, Springer Healthcare |
series |
Infectious Diseases and Therapy |
issn |
2193-8229 2193-6382 |
publishDate |
2020-09-01 |
description |
Abstract Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-19 pneumonia. Methods A retrospective study based on propensity score matching was designed to explore the effects of corticosteroids. Primary outcomes included the rate of patients who developed severe disease and mortality. Secondary outcomes included duration of fever, virus clearance time, length of hospital stay, and the use of antibiotics. Results A total of 475 patients with non-severe COVID-19 pneumonia were enrolled, 55 patients received early, low-dose, and short-term corticosteroids therapy, 420 patients received non-corticosteroids therapy. Compared to the non-corticosteroids group, there was a prolonged duration of fever (median 5 vs 3 days, p < 0.001), virus clearance time (median 18 vs 11 days, p < 0.001), and length of hospital stay (median 23 vs 15 days, p < 0.001) in the corticosteroids group. The percentages of antibiotics therapy (89.1% vs 23.6%, p < 0.001), use of at least two antibiotics (38.2% vs 12.7%, p = 0.002), and antifungal therapy (7.3% vs 0, p = 0.042) were higher in the corticosteroids group than those in the non-corticosteroids group. Compared to the non-corticosteroids group, more patients developed severe disease (12.7% vs 1.8%, p = 0.028) in the corticosteroids group. There was no significant difference between the two groups in mortality (1.8% vs 0, p = 0.315). Conclusion In adult patients with non-severe COVID-19 pneumonia, early, low-dose, and short-term corticosteroids therapy was associated with worse clinical outcomes. |
topic |
2019 novel coronavirus disease Corticosteroids Efficacy evaluation Non-severe COVID-19 infections Severe acute respiratory syndrome coronavirus 2 |
url |
https://doi.org/10.1007/s40121-020-00332-3 |
work_keys_str_mv |
AT qiangli efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT weixiali efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT yinpengjin efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT weixu efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT chenluhuang efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT lili efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT yuxianhuang efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT qingchunfu efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy AT liangchen efficacyevaluationofearlylowdoseshorttermcorticosteroidsinadultshospitalizedwithnonseverecovid19pneumoniaaretrospectivecohortstudy |
_version_ |
1717814427988787200 |